AI-PROGNOSIS - Digital Biomarkers Development Study (dBM-DEV)

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions
Parkinson Disease
Interventions
DEVICE

connected smartwatch

The smartwatch is worn by the patient and data are sent automatically to a server that detects if there are signs of RBD.

Trial Locations (4)

Unknown

Neurology Toulouse Hospital, Toulouse

Klinik und Poliklinik für Neurologie of University Hospital (Regulatory autorization pending), Dresden

Hospital Ruber Internacional, Madrid

King's college of London (Regulatory authorization pending), London

All Listed Sponsors
collaborator

European Union

OTHER

collaborator

University Hospital Carl Gustav Carus

OTHER

collaborator

Aristotle University Of Thessaloniki

OTHER

lead

University Hospital, Toulouse

OTHER

NCT06444789 - AI-PROGNOSIS - Digital Biomarkers Development Study (dBM-DEV) | Biotech Hunter | Biotech Hunter